EWM
EMN icon

Elevatus Welath Management’s Eastman Chemical EMN Stock Holding History

Elevatus Welath Management’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,636
Closed -$201K – 248
2026
Q1 		$201K Buy
+2,636
New +$190K 0.11% 135
2024
Q4 		– Sell
-2,041
Closed -$229K – 110
2024
Q3 		$229K Buy
+2,041
New +$204K 0.07% 88

Other funds holding EMN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Elevatus Welath Management's EMN Position: Q2 2026 in Review

Elevatus Welath Management sold out of Eastman Chemical (EMN) in Q2 2026, closing a stake of 2,636 shares — an estimated $201K sold.

Elevatus Welath Management first reported a position in EMN in Q3 2024 and held it in 2 quarters. The position peaked at $229K in Q3 2024. 647 funds tracked by Wall St. Rank hold EMN as of Q2 2026.

  • Elevatus Welath Management reported no remaining Eastman Chemical position as of Q2 2026 after selling out during the quarter.
  • Elevatus Welath Management sold 2,636 Eastman Chemical shares in Q2 2026, an estimated $201K.
  • Elevatus Welath Management first reported a position in Eastman Chemical in Q3 2024 and held it in 2 quarters.
  • Elevatus Welath Management's Eastman Chemical position peaked at $229K in Q3 2024.
  • 647 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.

Based on Elevatus Welath Management's 13F filing for Q2 2026, filed 13 Aug 2026.